Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03074149
What this trial is testing

Investigating Idiopathic Pulmonary Fibrosis in Greece

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 301
Large-scale testing (Phase 3)Active Not RecruitingNCT06003426
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb 1,255
Not applicableLooking for participantsNCT06162884
What this trial is testing

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of California, Los Angeles 200
Early research (Phase 1)Study completedNCT01385644
What this trial is testing

Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
The Prince Charles Hospital 8
Not applicableStudy completedNCT07119099
What this trial is testing

The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Marmara University 21
Testing effectiveness (Phase 2)Study completedNCT05722964
What this trial is testing

Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT01371305
What this trial is testing

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Biogen 41
Early research (Phase 1)Study completedNCT06589921
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 24
Early research (Phase 1)Study completedNCT05428150
What this trial is testing

Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis
Excalibur Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT01759511
What this trial is testing

Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Gilead Sciences 34
Not applicableLooking for participantsNCT06909409
What this trial is testing

D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
University of Aarhus 120
Not applicableStudy completedNCT01874223
What this trial is testing

Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Stanford University 40
Not applicableStudy completedNCT03268915
What this trial is testing

Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Grenoble 35
Not applicableStudy completedNCT03567785
What this trial is testing

Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
KU Leuven 66
Early research (Phase 1)Study completedNCT05684289
What this trial is testing

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 61
Early research (Phase 1)Study completedNCT00125385
What this trial is testing

Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genzyme, a Sanofi Company 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131150
What this trial is testing

Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Ruijin Hospital 66
Not applicableLooking for participantsNCT07482917
What this trial is testing

Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Suspected Interstitial Lung DiseaseFibrotic Interstitial Lung Disease+2 more
Hospital de Granollers 92
Early research (Phase 1)Study completedNCT01457261
What this trial is testing

IPF Drug Deposition Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 10
Testing effectiveness (Phase 2)Study completedNCT05938920
What this trial is testing

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
InSilico Medicine Hong Kong Limited 71
Next Page